Most RENOWNED Pharma Compliance Event

Best Practice
Compliance Strategies

Case Studies
In China’s Market Landscape




The 3rd Annual Pharmaceutical Compliance China conference will prepare participants in dealing with the latest legal landmines related to compliance, as well as equip them with an in-depth understanding of how to mitigate non- compliance risks at every part of the pharma value chain. Gain invaluable insight into best practices pertaining to internal compliance programs and third party due diligence and investigation strategies from top pharmaceutical companies and incorporate lessons into your own company for maximum benefit.



Featured Speakers

Patrick Kos
VP Compliance, Roche, China

Jifeng Shi
Director of Compliance and Registration Department, Fosun Pharma Group

Sharon Xie
Regional Quality Compliance & QP, Reckitt Benckiser, China

Clarissa Shen
Vice President China Compliance Officer, Sanofi, China

David Shen
VP Legal, General Counsel, AstraZeneca, China

Titi Zhang
Director, China Governance Operations|, GlaxoSmithKline

Wong Chae Sing
Head of Regional Compliance, (APAC, MEA and LATM), Mundipharma

Key Highlights / 关键亮点

Strategic & Operational Insights on China’s Pharma Compliance

GSK, Sanofi, Novartis, Takeda, Roche, BeiGene, AstraZeneca, Merck, Teva
Managing 3rd Party Compliance Risk in China

Assessing changing risks to strengthen business partnership in changing regulatory environment
Spotlight on Entire Pharma Value-Chain

Revitalising compliance strategies in all stages of pharma production to consumption
FMV Assessment

Understanding the process to engage HCP’s + HCO’s
Ensuring Patients Safety thru Effective Risk Management

Adopting key risk management principle across the value chain
IP & Competition Policy

Best Practices on ethical marketing and promotion
Understanding Data Integrity

Regulatory implications and real life case studies
Building Values and Ethics Based Culture

Challenges and strategy in creating ethical behavior
China’s Most RENOWNED Pharma Compliance Event

Featuring issues that matters and a platform for pharmaceutical leaders

Hear from past participants

“I found the meeting quite robust and certainly had a good and healthy exchange of knowledge. I would certainly be happy to participate in future initiatives and explore how these great meetings can be made more interactive and rewarding.”

Regional Medical Leader, Oncology, Asia Pacific Medical Affairs, Roche Pharmaceuticals
“Thank you for providing the platform which allows all experts to exchange and discuss thoughtful viewpoint inside of clinical trials industry. Your organization always impresses me.”

Vice Chairman, Asia Pacific, PAREXEL International
“Comprehensive conference covered most areas concerned by pharmaceutics, CRO and clinical trial centers in China. Different from clinical trial event, which often focus on one or two aspects of clinical trial.“

Director, Clinical Operations, TenNor Therapeutics
“This is a very worthwhile conference. In addition to the sessions, there are networking breaks that allow interaction between attendees at one of three sessions that take place concurrently.“

Director, Clinical Development and Medical Affairs, Respiratory Therapeutic Area, Boehringer Ingelheim Pharmaceuticals
“A very diverse panel of speakers and attendees.”

CEO, BARC Central Labs
“Very friendly and supportive staff - made the event a “hit” for us!”

Director, Business Development, Asia, INC Research
“Thanks so much for fantastic support before and during the event. It was a true pleasure working with you!”

Marketing Manager, APAC, PAREXEL International
“Footfall was good and the quality of people were great. Would recommend to our marketing manager”

Global Business Development Manager, MESM Global
“Very nicely done. Look forward to participating again next year”

Vice President, Business Development and General Manager, Asia, Indipharm


Part of

Co-Located Events

Contact Us